R R

What Is Macular Pigment Optical Density?

Macular pigment optical density, often shortened to MPOD, is a measure of how much macular pigment is present in the central retina. This pigment is largely made of the dietary carotenoids lutein and zeaxanthin, plus smaller amounts of meso-zeaxanthin. Macular pigment absorbs short-wavelength blue light and is linked to retinal light filtering and antioxidant protection. MPOD is a measurement, not a diagnosis, and it is interpreted alongside eye exam findings and risk factors.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is Macular Pigment Optical Density?

Macular pigment optical density, often shortened to MPOD, is a measure of how much macular pigment is present in the central retina. This pigment is largely made of the dietary carotenoids lutein and zeaxanthin, plus smaller amounts of meso-zeaxanthin. Macular pigment absorbs short-wavelength blue light and is linked to retinal light filtering and antioxidant protection. MPOD is a measurement, not a diagnosis, and it is interpreted alongside eye exam findings and risk factors.

read more about macular pigment optical density ...

Copy this HTML:

Copy HTML Copied!

What MPOD Measures

  • The relative density of macular pigment in the macula, especially near the fovea
  • How much blue light is absorbed by macular pigment at measured locations
  • A biomarker that may relate to visual performance factors like glare tolerance in some research settings

How MPOD Is Measured

MPOD can be measured using psychophysical methods and imaging-based methods. A common approach is heterochromatic flicker photometry, where the patient adjusts flicker perception to estimate pigment absorption. Other methods can include fundus autofluorescence, reflectometry, or similar optical techniques, depending on the clinic and device. Results can vary by method, so trends over time are often more useful than a single number.

Why MPOD Matters

MPOD is frequently discussed in the context of macular health and age-related macular degeneration risk research, but it does not diagnose macular degeneration on its own. Clinicians may use MPOD testing to support counseling on nutrition and eye health habits. MPOD can also be used in research and in some practices as part of broader ocular wellness assessments. Any concerns about central vision, distortion, or sudden blur should be evaluated with a dilated retinal exam.

Ways to Support Macular Pigment

  • Eat carotenoid-rich foods such as leafy greens and yellow or orange produce
  • Follow medical advice on supplements only when appropriate for your health profile
  • Protect eyes from excessive ultraviolet exposure with quality sunglasses
  • Manage smoking and cardiovascular risk factors that can affect overall retinal health

FAQs on MPOD

Is low MPOD a diagnosis?

No. Low MPOD is a measurement result that may reflect lower macular pigment density, but it does not diagnose a disease by itself. It should be interpreted with eye exam findings, imaging, and your personal risk factors.

Can supplements increase MPOD?

In some people, increasing intake of lutein and zeaxanthin through diet or supplements can raise MPOD over time, but response varies. Supplement decisions should consider overall health and should be guided by an eye care professional or clinician. Supplements do not replace eye exams or treatment when disease is present.

How long does it take for MPOD to change?

Changes are typically gradual. Many nutrition-based interventions are assessed over months rather than days, and individual response depends on baseline levels and absorption. Your clinic may recommend repeat testing to track trends.

Who might benefit from MPOD testing?

People interested in macular health monitoring, those with a family history of age-related macular degeneration, or patients who want nutrition counseling may consider MPOD testing. It can also be used in research and some preventive care settings. Testing is optional and should not delay evaluation of symptoms such as distortion or central scotomas.

References

Macular pigment optical density and measurement technology: clinical significance and research value. National Library of Medicine (PMC). https://pmc.ncbi.nlm.nih.gov/articles/PMC12120468/. 2025.

Macular Pigment Optical Density as a Measurable Modifiable Clinical Biomarker. National Library of Medicine (PMC). https://pmc.ncbi.nlm.nih.gov/articles/PMC11478551/. 2024.

Analysis of Macular Pigment Optical Density in [clinical study]. National Library of Medicine (PMC). https://pmc.ncbi.nlm.nih.gov/articles/PMC10787731/. 2024.

Macular pigment optical density change analysis in primary open-angle glaucoma (study record). Europe PMC. https://europepmc.org/article/med/33759069. 2021.

Macular pigment optical density (MPOD) (overview entry). Wikipedia. https://en.wikipedia.org/wiki/Macular_pigment_optical_density. August 1, 2024.